KRT19 and cancer: The integrative analysis identified PROX1+ LEC subsets, JAM2+ BECs, COL1A1+ stromal cells, PTPRC+ leukocytes, including MZB1+ plasmablasts, KRT19+ cancer cells, and MKI67+-proliferating cells (Supplementary Fig. 2b, c).